CD47 and neoplasm: Conversely, when EVs overexpress SIRPα, due to binding to CD47 on the surface of cancer cells, EVs disrupt the interaction of the cancer cell signaling CD47-SIRPα axis, resulting in increased phagocytosis of cancer cells by macrophages, thereby suppressing tumor growth.